Latest Press Releases

Health News Posted on Thursday, August 7, 2025

Premium Press Releases »

Accumulus Synergy Spins Out Accumulus Technologies to Scale Proven Regulatory Platform and Accelerate Global Access to Therapies

BURLINGAME, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a bold move to accelerate regulatory innovation and meet growing global demand, Accumulus Synergy, a nonprofit industry association, today announced the formation of Accumulus ...

Read More

Understanding Facial Paralysis: Its Causes and Treatments Along With Reasons for Recovery

Formally Defined Facial Paralysis and Its Impacts Facial paralysis is a medical condition that entails being unable to move the muscles on a person's face and is a multifaceted condition that comes with emotional, psychological, and ...

Read More

Press Releases »

Everhope Oncology Launches First Cancer Daycare Centre in Gurugram -- Revolutionizing Cancer Care with Compassion, Precision and Convenience

PR Newswire GURUGRAM, India, Aug. 6, 2025 Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance. GURUGRAM, India, Aug. 6, ...

Read More
Advertisement

From AI to Precision Medicine: Taiwan's Smart Healthcare Innovations Shine at Taiwan Expo USA 2025

PR Newswire DALLAS, Aug. 5, 2025 DALLAS, Aug. 5, 2025 /PRNewswire/ -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the Kay Bailey Hutchison Convention Center in Dallas, Texas, from August 14 to 16. Featuring two ...

Read More

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency

PR Newswire MILAN, Aug. 6, 2025 New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in ...

Read More

Medical College of Wisconsin Celebrates Grand Opening of the Center for Cancer Discovery, Heralding a New Era of Cancer Research in Wisconsin

PR Newswire MILWAUKEE, Aug. 5, 2025 MILWAUKEE, Aug. 5, 2025 /PRNewswire/ -- Today, the Medical College of Wisconsin (MCW) hosted a ribbon cutting ceremony to celebrate the grand opening of its new cancer research facility. The Center for ...

Read More
Advertisement

Breakthrough T1D, formerly JDRF, Leads Multi-Stakeholder Summit in Udaipur, India Highlighting Urgent Need for Early Diagnosis, Access to Care, and Stigma Reduction for Type 1 Diabetes

PR Newswire NEW YORK, Aug. 5, 2025 NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Breakthrough T1D International, the leading global type 1 diabetes (T1D) research and advocacy organization, in partnership with Friends of Mewar and UNICEF concluded ...

Read More

Legionnaires' Disease Lawyers Retained to Investigate Central Harlem Legionnaires' Disease Outbreak

PR Newswire HARLEM, N.Y., Aug. 5, 2025 HARLEM, N.Y., Aug. 5, 2025 /PRNewswire/ -- Legionnaires' disease lawyer Jory Lange and prominent Manhattan attorney Scott Harford have been retained to investigate an outbreak of Legionnaires' disease ...

Read More

Helping Children Manage Back-to-School Anxiety

PR Newswire MOBILE, Ala., Aug. 5, 2025 MOBILE, Ala., Aug. 5, 2025 /PRNewswire/ -- With the first day of school right around the corner, many children – and their parents – are experiencing a mix of excitement and worry. Experts remind ...

Read More

New Book Proposes Groundbreaking Link Between Neanderthal Genes and Bipolar Disorder

PR Newswire TUCSON, Ariz., Aug. 5, 2025 TUCSON, Ariz., Aug. 5, 2025 /PRNewswire/ -- A revolutionary theory that traces bipolar disorder to our Neanderthal ancestors is the subject of a provocative new book by psychologist and researcher ...

Read More

Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide"

PR Newswire PLAINSBORO, N.J., Aug. 5, 2025 PLAINSBORO, N.J., Aug. 5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain ...

Read More

JAMA Surgery Study Confirms Diagnostic Value of Cizzle Bio's DEX-G2 Blood Test For Early Detection of Gastric Cancer

PR Newswire SAN ANTONIO, Aug. 5, 2025 SAN ANTONIO, Aug. 5, 2025 /PRNewswire/ -- A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance of the Destinex assay, a novel ...

Read More

Successful Conclusion of Groundbreaking First-in-Human Trial for Revolutionary Non-Blood-Contacting reBEAT Heart Support Device, Clears Path for Transformative US study

PR Newswire MUNICH, Aug. 5, 2025 AdjuCor GmbH has successfully completed the world's First-in-Human clinical trial for its reBEAT extravascular cardiac support system, a groundbreaking device that supports the heart by gently squeezing it ...

Read More

AFFI Shares 10 Ways Frozen Foods Can Support National Health Goals

PR Newswire ARLINGTON, Va., Aug. 5, 2025 American Frozen Food Institute Releases Policy Recommendations for Make America Healthy Again Commission ARLINGTON, Va., Aug. 5, 2025 /PRNewswire/ -- The American Frozen Food Institute (AFFI) ...

Read More

Breakthroughs on the Horizon: Global Experts to Tackle Fastest-Growing Brain Disease at Major International Congress in Honolulu

PR Newswire HONOLULU, Aug. 5, 2025 The world's leading authorities on Parkinson's disease and other movement disorders — some of the most challenging and fastest-growing neurological conditions — will gather in Honolulu this October to chart ...

Read More

UCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

PR Newswire ATLANTA, Aug. 5, 2025 ATLANTA, Aug. 5, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, hosted its 2025 Hidradenitis Suppurativa (HS) Summit, which aimed to create a community forum for open discussion about HS, a ...

Read More

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight

PR Newswire HONG KONG, Aug. 5, 2025 -          13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity or overweight. ...

Read More

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

PR Newswire BOSTON and ROLLE, Switzerland, Aug. 5, 2025 BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, ...

Read More

New Technique Uses Focused Sound Waves and Holograms to Control Brain Circuits

PR Newswire NEW YORK, Aug. 5, 2025 NEW YORK, Aug. 5, 2025 /PRNewswire/ -- A new study provides the first visual evidence showing that brain circuits in living animals can be activated by ultrasound waves projected into specific patterns ...

Read More

As Students Go Back to School, New Study Highlights the Importance of Clean Air in Classrooms

PR Newswire CHICAGO, Aug. 5, 2025 American Lung Association Collaborates with Minnesota Charter School and Carrier to Support Student Health and Learning Environments CHICAGO, Aug. 5, 2025 /PRNewswire/ -- With students across the country ...

Read More

Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors

PR Newswire DONGGUAN, China, Aug 5, 2025 DONGGUAN, China, Aug 5, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient ...

Read More

Hemispherian Receives FDA IND Clearance for First-in-Class Glioblastoma Therapeutic, GLIX1

PR Newswire OSLO, Norway, Aug. 5, 2025 OSLO, Norway, Aug. 5, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, today announced that the U.S. Food and Drug ...

Read More

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

PR Newswire SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ...

Read More

Interstitial Cystitis Market to Grow Rapidly at a CAGR of 4% During the Study Period (2020-2034) | DelveInsight

PR Newswire LAS VEGAS, Aug 4, 2025 The interstitial cystitis market is limited by a few approved treatments and high unmet need. However, pipeline innovation and rising awareness are expected to drive modest growth and improve future ...

Read More

Microbiome Sequencing Market on the Rise: 19.3% CAGR Forecast

PR Newswire BOSTON, Aug. 4, 2025 "Driving Innovation Across Healthcare, Agriculture, and Environmental Science, Microbiome Sequencing Unlocks the Power of Microbial DNA to Enable Personalized Medicine, Sustainable Farming, and Ecosystem ...

Read More

The Hidden Lung Infection Impacting Millions: World NTM Day Puts Spotlight on Awareness

PR Newswire MIAMI, Aug. 4, 2025 With Annual NTM Case Rates Rising, Patients and Providers Are Urged to Recognize the Symptoms and Risks MIAMI, Aug. 4, 2025 /PRNewswire/ -- As the world prepares to observe World NTM Day on August 4, ...

Read More

Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD

PR Newswire LONDON, UK and BUDAPEST, HUNGARY, Aug. 4, 2025 LONDON, UK and BUDAPEST, HUNGARY, Aug. 4, 2025 /PRNewswire/ -- Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the ...

Read More

HKBU leads the development of multifunctional nanorobots for precise and effective pollutant degradation and bacterial removal

PR Newswire HONG KONG, Aug. 4, 2025 HONG KONG, Aug. 4, 2025 /PRNewswire/ -- A collaborative research team led by Hong Kong Baptist University (HKBU) has developed a multifunctional nanorobot equipped with silver and gold nanorods to ...

Read More

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

PR Newswire TAIPEI, Aug. 4, 2025 TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-301, enabling the ...

Read More

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

PR Newswire BEIJING, Aug. 3, 2025 BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing ...

Read More

Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma

PR Newswire HONG KONG, Aug. 4, 2025 HONG KONG, Aug. 4, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225) has been ...

Read More

Olaris to Present Results from Three Studies Showcasing Non-Invasive Urine Assays for Graft Injury Detection and Drug Compliance at 2025 World Transplant Congress

PR Newswire FRAMINGHAM, Mass., Aug. 3, 2025 Olaris will highlight data demonstrating the power of its myOLARIS™-KTdx urine-based diagnostic to detect and differentiate kidney graft injury with high accuracy. These findings represent a major ...

Read More
More Press Releases